Guess?, Inc. (NYSE:GES) was downgraded by investment analysts at TheStreet from a “buy” rating to a “hold” rating in a note issued to investors on Friday, StockRatingsNetwork reports. Guess?, Inc. (NYSE:GES) stock opened at $29.37 in last trading session, and closed at $29.85, trading in the range of $29.28 – $29.87. The stock showed a positive/negative weekly performance of -5.09%.
Shares of Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) are sharply lower in early trading after the FDA posted briefing documents related to a review of a resubmission for the company’s droxidopa drug. The documents are related to a cardiovascular and renal drug advisory committee meeting scheduled for January 14. Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) shares closed at $2.50 on last trade day, by losing -29.18%. Stock 52 week range is $0.76 – $4.53. Company’s market capitalization is $196.08 billion.
Natural Resource Partners LP (NYSE:NRP) is dropping like a stone on Friday after issuing disappointing 2014 guidance. By mid-morning, the stock had bombed 15.4% to $17.21. Natural Resource Partners LP (NYSE:NRP) stock decreased -18.39% and finished the last session at $16.60. The EPS of the stock remained 1.68. Company’s market capitalization is $1.82 billion.
MannKind Corporation (NASDAQ:MNKD) today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) is tentatively scheduled on April 1, 2014 to review MannKind’s New Drug Application (NDA) for AFREZZA(R) (insulin human [rDNA origin]) Inhalation Powder. The date and details of the meeting are subject to confirmation by the FDA in a Federal Register notice. MannKind resubmitted the NDA on October 13, 2013 seeking approval to market AFREZZA in the United States with an indication to improve glycemic control in adults with type 1 or type 2 diabetes. The target date for the FDA to complete its review of the AFREZZA NDA is April 15, 2014. MannKind Corporation (NASDAQ:MNKD) stock opened at $6.69 in last trading session and closed at $5.92. The 52 week range of the stock is $2.34 – $8.70 and the day range was $5.90 – $6.69.